Defiance Daily Target 2X Long LLY ETF(LLYX.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Defiance Daily Target 2X Long LLY ETF
LLYX.US
News
View More

17:52 ET CoreAge Rx Expands GLP-1 Access to Support New Year Weight Loss Goals

CoreAge Rx, a telehealth pharmacy, has announced an expansion of its compounded GLP-1 weight management program to support New Year's weight loss goals. This initiative aims to increase access to medications like tirzepatide and semaglutide, addressing barriers such as cost and supply shortages. The expansion includes enhancements to their digital platform and patient education resources, ensuring consistent medication availability. CoreAge Rx's telehealth model allows patients to manage their treatment online, making effective weight management more accessible as many Americans set health resolutions for 2026.

prnewswire·
US
ELIL
+0.42%
US
LLYX
+0.81%
prnewswire·
US
ELIL
+0.42%
US
LLYX
+0.81%

Dr. David Thrasher recognized as a healthcare leader, Eli Lilly to invest $6 billion in manufacturing facility in Alabama.

In a recent development, Alabama disclosed its largest-ever investment with pharmaceutical giant Eli Lilly. The company, valued as the world's most valuable in the field, is set to construct a cutting-edge manufacturing plant worth $6 billion in Huntsville. This significant endeavor marks a pivotal moment for the state's economic landscape.

Unusual Whales·
US
ELIL
+0.42%
US
LLYX
+0.81%
Unusual Whales·
US
ELIL
+0.42%
US
LLYX
+0.81%

BUZZ-Abivax rises as another media report feeds M&A chatter

Shares of Abivax (ABVX.PA) rose 6% amid M&A speculation, following a report that AstraZeneca (AZN.L) offered approximately 176 euros ($205.85) per share. Analysts from Kepler Chevreux and ODDO BHF attributed the stock's volatility to this news. Previously, Eli Lillywas rumored to be preparing a 15 billion euro ($17.5 billion) bid, although France’s Finance Ministry has not received any formal investment request. Both AstraZeneca and Abivax did not provide immediate comments on the matter.

Reuters·
US
LLYX
+0.81%
UK
AZN
0.00%
US
AZNH
-4.99%
Reuters·
US
LLYX
+0.81%
UK
AZN
0.00%
US
AZNH
-4.99%

Sector Update: Health Care Stocks Lower in Afternoon Trading

Health care stocks experienced a slight decline, with the NYSE Health Care Index down 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.3%. Capricor Therapeutics (CAPR) shares fell 2.3% following an FDA request for a full clinical study report. Qiagen (QGEN) shares surged 19% amid takeover interest, while Abivax (ABVX) shares rose 0.5% after its CEO dismissed takeover rumors from Eli Lilly (LLY), which saw a 0.2% increase.

fidelity·
US
ABVX
+1.49%
US
LLYX
+0.81%
US
ELIL
+0.42%
fidelity·
US
ABVX
+1.49%
US
LLYX
+0.81%
US
ELIL
+0.42%

Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 5 Years

Eli Lilly and Co (NYSE:LLY) has outperformed the market by 25.43% annually over the past 5 years, yielding an average annual return of 37.44%. With a market cap of $931.63 billion, a $1000 investment in LLY stock five years ago would now be worth $5,051.37, based on the current price of $1040.90. This highlights the significant impact of compounded returns on investment growth over time.

benzinga_article·
US
LLYX
+0.81%
US
ELIL
+0.42%
benzinga_article·
US
LLYX
+0.81%
US
ELIL
+0.42%
© 2026 Longbridge｜Disclaimer